Acute Respiratory Infection Clinical Trial
Verified date | December 2012 |
Source | Mead Johnson Nutrition |
Contact | n/a |
Is FDA regulated | No |
Health authority | Brazil: HUPES Complex Ethics Committee (CEP) |
Study type | Interventional |
The purpose is to determine if the consumption of study product has an effect on acute respiratory infections and/or diarrheal disease.
Status | Completed |
Enrollment | 250 |
Est. completion date | May 2012 |
Est. primary completion date | May 2012 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 12 Months to 48 Months |
Eligibility |
Inclusion Criteria: - Child 12-48 months of age - Has consumed cow's milk or a cow's milk-based beverage during the 48 hours prior to randomization - Signed informed consent Exclusion Criteria: - Child who is receiving predominantly breast-milk - Child who received any food product or supplement containing probiotics or prebiotics in the 15 days prior to randomization - Child with allergy to gluten or serious concurrent illness that will interfere in the general management of the child - Child with diarrhea or acute respiratory infection during the 48 hours prior to randomization - Child's z-score of weight for length/height < -3 according to World Health Organization criteria |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Brazil | Universidade Federal da Bahia, Hospital Universitário Prof. Edgard Santos Complexo HUPES, Centro Pediátrico Professor Hossanah Oliveira, Centro da Pesquisas Fima Lifshitz, Rua Augusto Viana s/n Canela | Salvador | Bahia |
Lead Sponsor | Collaborator |
---|---|
Mead Johnson Nutrition | Federal University of Bahia |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Episodes of acute respiratory infections and diarrheal disease | 28 weeks | No | |
Secondary | Occurrence of allergic manifestations | 28 weeks | No | |
Secondary | Systemic antibiotic use | 28 weeks | No | |
Secondary | Duration of acute respiratory infection and diarrheal disease | 28 weeks | No | |
Secondary | Changes in stool patterns | 28 weeks | No | |
Secondary | Fecal and serum immune markers | 28 weeks | No | |
Secondary | Serum Ferritin and Zinc status | 28 weeks | No | |
Secondary | Incidence of stool parasites | 28 weeks | No | |
Secondary | Growth | 28 weeks | No | |
Secondary | Incidence of adverse events | The incidence of any adverse event for each participant | 28 weeks | No |
Secondary | Acceptance of study product | Acceptance of study product based on quantity consumed | 28 weeks | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03943654 -
Improving Nighttime Access to Care and Treatment (Part 2)
|
||
Completed |
NCT05269290 -
Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections
|
Phase 3 | |
Completed |
NCT06385821 -
A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus
|
Phase 3 | |
Not yet recruiting |
NCT05902702 -
Isotonic Saline for Children With Bronchiolitis
|
N/A | |
Not yet recruiting |
NCT04525118 -
Wide Scale Monitoring for Acute Respiratory Infection Using a Mobile-based Study Platform
|
||
Completed |
NCT00981513 -
Direct and Indirect Benefits of Influenza Vaccination in Schools and Households
|
Phase 4 | |
Recruiting |
NCT06183229 -
Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and Influenza
|
Phase 3 | |
Completed |
NCT03274310 -
FluSAFE: Flu SMS Alerts to Freeze Exposure
|
N/A | |
Completed |
NCT03736096 -
Molecular Diagnosis of Respiratory Viral Infections on Sputum From Cystic Fibrosis Patients
|
||
Completed |
NCT03189537 -
Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections
|
Phase 3 | |
Completed |
NCT03028077 -
Effects of GS-3K8 and GINst15 on Acute Respiratory Illness
|
N/A | |
Enrolling by invitation |
NCT01286285 -
Surveillance of Influenza in Paediatric Intensive Care Units in Bavaria
|
N/A | |
Completed |
NCT03840135 -
Efficacy and Safety of Polyoxidonium, Nasal and Sublingual Spray, 6 mg/ml in Children Aged 1-12 Years With ARI
|
Phase 3 | |
Completed |
NCT01488435 -
Efficacy and Tolerance of a Follow-On Formula Fed to Children From 36-48 Months of Age
|
N/A | |
Not yet recruiting |
NCT00545961 -
Middle Meatal Bacteriology During Acute Respiratory Infection in Children
|
Phase 4 | |
Completed |
NCT05273619 -
Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection
|
Phase 3 | |
Recruiting |
NCT04415827 -
Energy Supply in Athletes and Untrained Persons With Bronchopulmonary Diseases
|
N/A | |
Completed |
NCT03459391 -
Study to Assess Safety, Tolerability and Pharmacokinetics of XC221 in Healthy Volunteers
|
Phase 1 | |
Withdrawn |
NCT04938323 -
Prevention of Acute Respiratory Infection in Taiwanese Institutionalized Elderly
|
Phase 2/Phase 3 | |
Completed |
NCT01693380 -
Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza
|
Phase 4 |